Abstract:Background: Hepatic ischemia and reperfusion (I/R) injury is commonly associated with surgical liver resection or transplantation, and represents a major cause of liver damage and graft failure. Currently, there are no effective therapies to prevent hepatic I/R injury other than ischemic preconditioning and some preventative strategies. Previously, we have revealed the anti-inflammatory activity of a sweat gland-derived peptide, dermcidin (DCD), in macrophage/monocyte cultures. Here, we sought to explore its therapeutic potential and protective mechanisms in a murine model of hepatic I/R. Methods: Male C57BL/6 mice were subjected to hepatic ischemia by clamping the hepatic artery and portal vein for 60 min, which was then removed to initiate reperfusion. At the beginning of reperfusion, 0.2 ml saline control or solution of DCD (0.5 mg/kg BW) or DCD-C34S analog (0.25 or 0.5 mg/kg BW) containing a Cys (C)→Ser (S) substitution at residue 34 was injected via the internal jugular vein. For survival experiments, mice were subjected to additional resection to remove non-ischemic liver lobes, and animal survival was monitored for 10 days. For mechanistic studies, blood and tissue samples were collected at 24 h after the onset of reperfusion, and subjected to measurements of various markers of inflammation and tissue injury by real-time RT-PCR, immunoassays, and histological analysis. Results: Recombinant DCD or DCD-C34S analog conferred a significant protection against lethal hepatic I/R when given intravenously at the beginning of reperfusion. This protection was associated with a significant reduction in hepatic injury, neutrophilic CXC chemokine (Mip-2) expression, neutrophil infiltration, and associated inflammation. Furthermore, the administration of DCD also resulted in a significant attenuation of remote lung inflammatory injury. Mechanistically, DCD interacted with epidermal growth factor receptor (EGFR), a key regulator of liver inflammation, and significantly inhibited hepatic I/R-induced phosphorylation of EGFR as well as a downstream signaling molecule, protein kinase B (AKT). The suppression of EGFR expression by transducing Egfr-specific shRNA plasmid into macrophages abrogated the DCD-mediated inhibition of nitric oxide (NO) production induced by a damage-associated molecular pattern (DAMP), cold-inducible RNA-binding protein, CIRP. Conclusions: The present study suggests that human DCD and its analog may be developed as novel therapeutics to attenuate hepatic I/R-induced inflammatory injury possibly by impairing EGFR signaling.

DIDS alleviates hepatic ischemia-reperfusion injury by inhibiting the opening of type 2 chloride channel in rats

DIDS reduces ischemia/reperfusion-induced myocardial injury in rats.

Effects of DIDS on Cardiac Hemodynamic Parameters,arrhythmia and CK/LDH Activity of Rats with Ischemia/reperfusion Injury

Preconditioning and Postconditioning Reduce Hepatic Ischemia-Reperfusion Injury in Rats

Protective Effects of DIDS Against Ethanol-Induced Gastric Mucosal Injury in Rats

Dids Protects Against Neuronal Injury by Blocking Toll-Like Receptor 2 Activated-Mechanisms

Protective effect of pyrrolidine dithiocarbamate on acute liver injury induced by ischemia reperfusion

Effect of Docosahexaenoic Acid on Hepatic Ischemia-Reperfusion Injury in Rats

The Effects of Diazoxide Pretreatment on Warm Ischemia-reperfusion Injury in Hepatic Sinusoidal Endothelium of Rats

The Triterpenoid CDDO-imidazolide Ameliorates Mouse Liver Ischemia-Reperfusion Injury Through Activating the Nrf2/HO-1 Pathway Enhanced Autophagy

Isothiocyanate Attenuates Ischemia‐induced Cell Death

Tanshinone IIA Pretreatment Attenuates Hepatic Ischemia-Reperfusion.

TAK242 suppresses the TLR4 signaling pathway and ameliorates DCD liver IRI in rats

Codonopsis lanceolata saponin preconditioning alleviates hepatic ischemia/reperfusion injury in rats

The Strategy of Combined Ischemia Preconditioning and Salvianolic Acid-B Pretreatment to Prevent Hepatic Ischemia-Reperfusion Injury in Rats

Effects of IL-22 on hepatic ischemia-reperfusion injury and related mechanism in SD rats

The anion transport inhibitor DIDS increases rat hepatocyte K+ conductance via uptake through the bilirubin pathway.

Effects of Dexmedetomidine on Hepatic Ischemia Reperfusion Injury in Rats with Cholestasis and Liver Fibrosis

Protective effect of Lidan Xiaohuang decoction on hepatic ischemia reperfusion oxidative stress in rats

The Effect of DIDS on Phosphatidylinositol 3'-Kinase/Proteinase B Signal Transduction of Staurosporine-Induced Cardiomyocyte Apoptosis

Human Dermcidin Protects Mice Against Hepatic Ischemia-Reperfusion-Induced Local and Remote Inflammatory Injury